Continue Reading
Full article on Yahoo Finance
PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know
Market Intelligence Analysis
AI-Powered 90% GROQ-LLAMA-3.1-8B-INSTANT
Why This Matters
Stocks including PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx are falling due to a hotter-than-expected wholesale inflation report, which suggests persistent price pressures.
Market Impact
Market impact analysis based on bearish sentiment with 90% confidence.
Sentiment
Bearish
AI Confidence
90%
Time Horizon
Short Term
Article Context
Note: This is a brief excerpt for context. Click below to read the full article on the original source.
A number of stocks fell in the afternoon session after a surprisingly hot wholesale inflation report fueled investor concerns about persistent price pressures. The Producer Price Index (PPI), a key measure of inflation at the wholesale level, increased by 0.5% in January, significantly higher than the 0.3% anticipated by economists. More concerning was the core PPI, which excludes volatile food and energy prices, as it surged by 0.8%, far exceeding the expected 0.3% rise. This data suggests that
AI Breakdown
Summary
Stocks including PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx are falling due to a hotter-than-expected wholesale inflation report, which suggests persistent price pressures.
Market Impact
Market impact analysis based on bearish sentiment with 90% confidence.
Time Horizon
Short Term
Original article published by
Yahoo Finance
on February 28, 2026.
Analysis and insights provided by AnalystMarkets AI.
Analysis and insights provided by AnalystMarkets AI.